Skip to main content

Table 4 Comparison between the BD and Non-BD groups

From: Diagnosis of Behçet’s disease: clinical characteristics, diagnostic criteria, and differential diagnoses

Symptom/Sign/Lab test

BD group, No. positive (percent)

Non-BD group, No. positive (percent)

P-value

Oral lesions

40 (100%)

83 (89.25%)

0.031

Genital lesions

26 (65%)

17 (18.28%)

<  0.001

Ocular lesions

20 (50%)

13 (13.98%)

<  0.001

Erythema Nodosum

11 (27.5%)

0 (0%)

<  0.001

Articular involvement

10 (25%)

13 (14%)

0.123

Pseudofolliculitis

3 (7.5%)

0 (0%)

0.008

Gastrointestinal

3 (7.5%)

12 (12.9%)

0.18

Cardiovascular

2 (5%)

2 (2.1%)

0.51

Neurologic involvement

1 (2.5%)

2 (2.1%)

0.9

Positive Pathergy reaction

18 (45%)

0

<  0.001

Leukocyte antigens

 HLA-B5

26 (65%)

46 (49%)

0.09

HLA-B51

24 (60%)

36 (38%)

0.02

 HLA-B27

3 (7.5%)

9 (9.6%)

0.68

  1. History, physical examination, and laboratory tests compared between BD and Non-BD groups, sorted by decreasing frequency in the BD group. Significant comparisons are indicated in bold